Nordicus Partners Corporation (NORD)
OTCMKTS
· Delayed Price · Currency is USD
8.80
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Nordicus Partners Revenue
Nordicus Partners had revenue of $2.50K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $5.00K. In the fiscal year ending March 31, 2024, Nordicus Partners had annual revenue of $2.50K.
Revenue (ttm)
5.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
163.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 2.50K | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNordicus Partners News
- 8 days ago - Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin's Breakthrough Treatment for Periodontitis - GlobeNewsWire
- 5 weeks ago - Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025 - GlobeNewsWire
- 6 weeks ago - NORDICUS now trading under symbol NORD - GlobeNewsWire
- 2 months ago - Nordicus Partners Corporation Acquires the Remaining 5% Shares In Orocidin A/S - GlobeNewsWire
- 2 months ago - Nordicus Partners Corporation Acquires Bio-Convert ApS - GlobeNewsWire
- 2 months ago - Nordicus Partners Corporation Announces Reverse Stock Split - GlobeNewsWire
- 7 months ago - Nordicus Partners To Host Investor Relations Webinar on July 10, 2024 - GlobeNewsWire
- 7 months ago - Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark - GlobeNewsWire